The problem
Tuberculosis (TB) medicines are critical for treating disease and stopping transmission. But delays and interruptions to medicine supplies can leave people unable to complete treatment, which contributes to more severe illness and the development of drug-resistance.
Download the evaluation
Our response
This project, led by the Global Drug Facility, supported the purchase of first-line TB treatment by creating strategic stockpiles of these drugs. The project increased the number of quality-approved manufacturers of TB drugs and negotiated lower prices for these medicines.
